Russell Investments Group
NAGE icon

Russell Investments Group’s Niagen Bioscience NAGE Stock Holding History

Russell Investments Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.8K Buy
30,023
+25,391
+548% +$103K ﹤0.01% 3458
2026
Q1 		$20.4K Sell
4,632
-32,362
-87% -$175K ﹤0.01% 3618
2025
Q4 		$235K Buy
36,994
+726
+2% +$5.05K ﹤0.01% 2783
2025
Q3 		$338K Buy
36,268
+14,518
+67% +$147K ﹤0.01% 2626
2025
Q2 		$313K Buy
21,750
+4,341
+25% +$42.9K ﹤0.01% 2507
2025
Q1 		$120K Buy
+17,409
New +$109K ﹤0.01% 2716
2021
Q3 		– Sell
-37,026
Closed -$365K – 3245
2021
Q2 		$365K Buy
+37,026
New +$323K ﹤0.01% 2713

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Russell Investments Group's NAGE Position: Q2 2026 in Review

Russell Investments Group increased its Niagen Bioscience (NAGE) stake by 548% in Q2 2026, buying an estimated $103K and bringing the position to 30,023 shares worth $95.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3458.

Russell Investments Group first reported a position in NAGE in Q2 2021 and has held it in 7 quarters since. The position peaked at $365K in Q2 2021. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Russell Investments Group held 30,023 shares of Niagen Bioscience worth $95.8K as of Q2 2026.
  • Russell Investments Group bought 25,391 Niagen Bioscience shares in Q2 2026, an estimated $103K.
  • Niagen Bioscience made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3458 holding.
  • Russell Investments Group first reported a position in Niagen Bioscience in Q2 2021 and has held it in 7 quarters since.
  • Russell Investments Group's Niagen Bioscience position peaked at $365K in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.